BREAKING
Valero Energy Corporation (VLO) Jumps 5.4% to $247.27 10 hours ago Amkor Technology, Inc. (AMKR) Drops 5.1% to $47.41 11 hours ago Commercial Metals Company (CMC) Q2 2026 Earnings Recap 11 hours ago Sandisk Corporation (SNDK) Drops 6.3% to $635.48 11 hours ago META (META) Drops 6.7% to $555.09 11 hours ago REX American Resources Corporation (REX) Q4 2025 Earnings Recap 11 hours ago H.B. Fuller Company (FUL) Q1 Earnings: Beats on EPS, Revenue Recap 12 hours ago WhiteFiber, Inc. (WYFI) Q4 Earnings: Misses on EPS, Revenue Recap 12 hours ago Foresight Autonomous Holdings Ltd. (FRSX) Reports Q4 Earnings 14 hours ago GigaMedia Limited (GIGM) Reports Q4 Earnings 14 hours ago Valero Energy Corporation (VLO) Jumps 5.4% to $247.27 10 hours ago Amkor Technology, Inc. (AMKR) Drops 5.1% to $47.41 11 hours ago Commercial Metals Company (CMC) Q2 2026 Earnings Recap 11 hours ago Sandisk Corporation (SNDK) Drops 6.3% to $635.48 11 hours ago META (META) Drops 6.7% to $555.09 11 hours ago REX American Resources Corporation (REX) Q4 2025 Earnings Recap 11 hours ago H.B. Fuller Company (FUL) Q1 Earnings: Beats on EPS, Revenue Recap 12 hours ago WhiteFiber, Inc. (WYFI) Q4 Earnings: Misses on EPS, Revenue Recap 12 hours ago Foresight Autonomous Holdings Ltd. (FRSX) Reports Q4 Earnings 14 hours ago GigaMedia Limited (GIGM) Reports Q4 Earnings 14 hours ago
ADVERTISEMENT
MRNA

Moderna, Inc

$MRNA NASDAQ Feb 13, 2026 BMO Q4 2025

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

MRNA Coverage

Transcript Moderna, Inc (MRNA) Q4 2025 Earnings Call Transcript Mar 10, 2026 Event Moderna, Inc (MRNA) Sec Form 8K Mar 6, 2026 Event Moderna, Inc (MRNA) Moderna Resolves Global Patent Litigation with Arbutus/Genevant Mar 3, 2026 Event Moderna, Inc (MRNA) European Medicines Agency’s Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19 Feb 27, 2026 News Moderna Q4 2025 net loss narrows; revenue drops 30% Feb 16, 2026 News Moderna Reports 4Q Revenue Of $678 Million, Projects 2026 Growth Feb 13, 2026 Transcript Moderna, Inc (MRNA) Q2 2022 Earnings Call Transcript Jan 27, 2026 Transcript Moderna, Inc (MRNA) Q2 2025 Earnings Call Transcript Jan 22, 2026